Skip to main content

This job has expired

Project Team Leader - Ophthalmology

Job Details

In Roche pRED Ophthalmology TA part of the I2O DTA (Immunology, Infectious Diseases and Ophthalmology), we combine world-leading science in areas where we have a long and successful track record with new avenues of research that hold tremendous promise for millions of patients and their caregivers worldwide.

The Project Team Leader (PTL) in ophthalmology is a senior leader within pRED and acts as the “General Manager” of projects, which means assuming full accountability for the delivery of assigned project(s) (strategy & budget), improving its value for pRED and Roche within the program’s strategic context as agreed with Governance Committees.

 

You will represent the best interests of the project and Roche by providing high quality strategic leadership to early global cross-functional disease area project teams within pRED.

You will define, lead, motivate, challenge and organize the global project team collectively and individually to define and execute a cutting-edge project strategy in accordance with its goals and budget and in alignment to the Ophthalmology TA.

 

To be more specific, you will:

  • Lead the project team in defining a clear vision, strategy, objectives and overarching plan. Ensuring the incorporation of options according to the principles of time, cost and risk and addresses technical, regulatory, business and operational needs.
  • Enable a seamless transition to Late Development by ensuring top quality input into the early development strategy from colleagues outside pRED, including clinical development, commercial, regulatory and safety colleagues. You will provide critical, cross-functional input into disease area (and pRED ) strategy.
  • Be accountable for the identification, prioritization and facilitation all key decisions associated with assigned projects
  • Set clear direction for the global early development strategy from CCS to POC, assuring deliverables are met for project transition to lifecycle
  • Resolve critical issues that impact the value of the project
  • Be accountable for ensuring that all team members and functions are aligned behind the objectives of the team and inspires team to achieve challenging goals
  • Interact with functions to ensure that appropriate resources are allocated at the appropriate time and aligned with agreed plan. Intensifies expediently if resource and budget impedes progress according to agreed plan
  • Lead teams to create and document an integrated early research and development project plan and secures agreement on transition plan for life cycle transition of project in direct
  • Serve as the interface between the TA (Translational Area) and partner functions on project-related issues; builds effective cross-functional working

 

Who you are:

A Scientific background in Ophthalmology ideally completed by a MBA or equivalent with at least 8 years in the pharmaceutical or biotech companies with a broad cross-functional experience in drug development, in early stage is required.

As a senior leader in our organization, possessing a strong strategic acumen, not only within assigned projects but in contribution to larger disease area strategies as well as exemplary matrix team leadership skills, is required.

You can justify a strong track record in influencing and inspiring teams and senior management, delivering a clear and compelling narrative for their project(s), and be able to advocate successfully at that level.

You demonstrated your knowledge of the scientific, technical, regulatory and business requirements for successful development projects and are familiar with budget preparation/analysis and handling multidisciplinary teams in a global and matrix environment.

You have excellent communication and presentation skills.

 

If you still have questions then please check our FAQs and videos on careers.roche.ch/faq.

Roche is an equal opportunity employer.

Company

About Roche


Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2018 employed about 94,000 people worldwide. In 2018, Roche invested CHF 11 billion in R&D and posted sales of CHF 56.8 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

All trademarks used or mentioned in this release are protected by law.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert